000282564 001__ 282564
000282564 005__ 20251202144558.0
000282564 0247_ $$2doi$$a10.1007/s00115-025-01808-8
000282564 0247_ $$2pmid$$apmid:40016477
000282564 0247_ $$2pmc$$apmc:PMC12662853
000282564 0247_ $$2ISSN$$a0028-2804
000282564 0247_ $$2ISSN$$a1433-0407
000282564 037__ $$aDZNE-2025-01327
000282564 041__ $$aGerman
000282564 082__ $$a610
000282564 1001_ $$aBeeke, M.$$b0
000282564 245__ $$aBeobachtungsstudie zur Koinzidenz von Alzheimer-Erkrankung und idiopathischem Normaldruckhydrozephalus: Analyse von Koinzidenz, deren Einfluss auf das Ansprechen im Liquorablassversuch und zerebrovaskulärer Kopathologie | Observational study on the coincidence of Alzheimer's disease and idiopathic normal pressure hydrocephalus: analysis of coincidence, the influence on response to cerebrospinal fluid drainage and cerebrovascular copathology
000282564 260__ $$aHeidelberg$$bSpringer$$c2025
000282564 3367_ $$2DRIVER$$aarticle
000282564 3367_ $$2DataCite$$aOutput Types/Journal article
000282564 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1764682961_28228
000282564 3367_ $$2BibTeX$$aARTICLE
000282564 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000282564 3367_ $$00$$2EndNote$$aJournal Article
000282564 520__ $$aAnalysis of the frequency of comorbid Alzheimer's disease in patients with suspected idiopathic normal pressure hydrocephalus (iNPH) and its effects on the response to cerebrospinal fluid (CSF) drainage as well as analysis of the frequency of a vascular copathology in patients with suspected iNPH.This was a prospective observational analysis of patients with suspected iNPH who underwent guideline-conform NPH routine diagnostics including CSF drainage during clinical routine diagnostics between 1 July 2022 and 30 June 2023. Patients were recruited via the departments of neurology, neurosurgery and psychiatry of the University Hospital Carl Gustav Carus in Dresden. Typical NPH imaging results were acquired from available magnetic resonance imaging (MRI) and computed tomography (CT) sectional images. Relevant sociodemographic, clinical, cognitive and CSF diagnostic parameters were acquired via patient chart review. The patients were categorized with respect to the CSF results according to the amyloid-tau-neurodegeneration (ATN) classification.During the observational period 33 patients (14 female, 19 male, mean age 74.6 ± 8.1 years) with suspected iNPH were analyzed. Of the patients 19 (57.6%) had a complete and 14 (42.4%) an incomplete Hakim's triad. The difference between the MoCA scores before and after CSF drainage varied between patients with and without a response to CSF drainage (F(1;22) = 5.725; p = 0.026). There was a trend that patients with a pathological corpus callosum angle and conspicuous Evans index (p = 0.052) as well as patients with a pathological corpus callosum angle, Evans index and complete clinical Hakim's triad (p = 0.055) more frequently show a response. The mean Fazekas score was 1.7. There was no correlation between the Fazekas score and response to CSF drainage. In 25 patients (75.8%) biomarkers for dementia and neurodegeneration were detected. According to the ATN classification 20 patients (80%) were categorized as A+T-, 3 (12.0%) as A+T+ and 2 (8.0%) as A-T-. Patients classified as A+T+ and A+T- did not respond more often to CSF drainage (p = 0.600).The combined determination of the corpus callosum angle and the Evans index as well es their contextualization with clinical characteristics can possibly improve the prognostic evaluation regarding response to CSF draínage. Especially a comorbid amyloid pathology and a cerebral microangiopathy represent frequent copathologies of iNPH but the influence on the response to CSF drainage remains to be elucidated.
000282564 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000282564 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000282564 650_7 $$2Other$$aCorpus callosum angle
000282564 650_7 $$2Other$$aEvans index
000282564 650_7 $$2Other$$aHakim’s triad
000282564 650_7 $$2Other$$aSpinal drainage
000282564 650_7 $$2Other$$aVascular copathology
000282564 650_2 $$2MeSH$$aHumans
000282564 650_2 $$2MeSH$$aHydrocephalus, Normal Pressure: epidemiology
000282564 650_2 $$2MeSH$$aHydrocephalus, Normal Pressure: therapy
000282564 650_2 $$2MeSH$$aHydrocephalus, Normal Pressure: diagnosis
000282564 650_2 $$2MeSH$$aHydrocephalus, Normal Pressure: cerebrospinal fluid
000282564 650_2 $$2MeSH$$aHydrocephalus, Normal Pressure: complications
000282564 650_2 $$2MeSH$$aFemale
000282564 650_2 $$2MeSH$$aMale
000282564 650_2 $$2MeSH$$aAged
000282564 650_2 $$2MeSH$$aAlzheimer Disease: epidemiology
000282564 650_2 $$2MeSH$$aAlzheimer Disease: cerebrospinal fluid
000282564 650_2 $$2MeSH$$aAlzheimer Disease: diagnosis
000282564 650_2 $$2MeSH$$aAlzheimer Disease: complications
000282564 650_2 $$2MeSH$$aAlzheimer Disease: therapy
000282564 650_2 $$2MeSH$$aAged, 80 and over
000282564 650_2 $$2MeSH$$aProspective Studies
000282564 650_2 $$2MeSH$$aMagnetic Resonance Imaging
000282564 650_2 $$2MeSH$$aDrainage
000282564 650_2 $$2MeSH$$aComorbidity
000282564 650_2 $$2MeSH$$aMiddle Aged
000282564 7001_ $$aSauer, C.$$b1
000282564 7001_ $$aPetzold, J.$$b2
000282564 7001_ $$0P:(DE-HGF)0$$aSchneider, S.$$b3
000282564 7001_ $$aFrenzen, K.$$b4
000282564 7001_ $$0P:(DE-HGF)0$$aDonix, M.$$b5
000282564 7001_ $$aReiß, G.$$b6
000282564 7001_ $$0P:(DE-2719)2812107$$aBrandt, Daniel Moritz$$b7$$udzne
000282564 7001_ $$aHaußmann, R.$$b8
000282564 773__ $$0PERI:(DE-600)1462945-8$$a10.1007/s00115-025-01808-8$$gVol. 96, no. 7, p. 686 - 695$$n7$$p686 - 695$$tDer Nervenarzt$$v96$$x0028-2804$$y2025
000282564 8564_ $$uhttps://pub.dzne.de/record/282564/files/DZNE-2025-01327.pdf$$yRestricted
000282564 8564_ $$uhttps://pub.dzne.de/record/282564/files/DZNE-2025-01327.pdf?subformat=pdfa$$xpdfa$$yRestricted
000282564 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812107$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000282564 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000282564 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-07$$wger
000282564 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-07$$wger
000282564 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNERVENARZT : 2022$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000282564 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-07
000282564 9201_ $$0I:(DE-2719)1710012$$kAG Falkenburger$$lTranslational Parkinson Research$$x0
000282564 980__ $$ajournal
000282564 980__ $$aEDITORS
000282564 980__ $$aVDBINPRINT
000282564 980__ $$aI:(DE-2719)1710012
000282564 980__ $$aUNRESTRICTED